Security · CUSIP 02083G100
ALPINE IMMUNE SCIENCES INC
COM · institutional ownership from 13F filings
13F holders
0
Shares held
0
Value held
$0
New / sold out
0 / 180
Added / reduced
0 / 0
net -66.1M shares
13F holders by quarter
Net shares bought by existing holders
Top holders · Q2 2024
Nothing to show.
Biggest buyers
Nothing to show.
Biggest sellers
| Manager | Change | Shares change | Change % |
|---|---|---|---|
| Decheng Capital LLC | Sold out | -8,317,924 | -100.0% |
| Avoro Capital Advisors LLC | Sold out | -5,775,000 | -100.0% |
| BlackRock Inc. | Sold out | -3,575,092 | -100.0% |
| Frazier Life Sciences Management, L.P. | Sold out | -3,131,008 | -100.0% |
| PRICE T ROWE ASSOCIATES INC /MD/ | Sold out | -3,080,220 | -100.0% |
| STATE STREET CORP | Sold out | -2,845,839 | -100.0% |
| VANGUARD GROUP INC | Sold out | -2,712,285 | -100.0% |
| Cormorant Asset Management, LP | Sold out | -2,700,000 | -100.0% |
| ORBIMED ADVISORS LLC | Sold out | -2,680,496 | -100.0% |
| MORGAN STANLEY | Sold out | -2,368,935 | -100.0% |
170 more rows. Subscribe for $29/month to see every row, download the data and use the API.